Pilot study: a detailed analysis of the timing of immuno-inflammatory indices in gastric cancer, and their assessment together with TNM as supplementary prognostic factors.

Sánchez Fuentes, Pedro Antonio; Ruiz-Pardo, José; Vidaña Márquez, Elisabet; Belda Lozano, Ricardo; Ferrer-Márquez, Manuel; Reina Duarte, Ángel

Sánchez Fuentes, Pedro Antonio; Ruiz-Pardo, José; Vidaña Márquez, Elisabet; Belda Lozano, Ricardo; Ferrer-Márquez, Manuel; Reina Duarte, Ángel.

Affiliation

Sánchez Fuentes PA; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España.
Ruiz-Pardo J; Cirugia General y del Aparato Digestivo, Hospital Universitario Torrecárdenas.
Vidaña Márquez E; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas.
Belda Lozano R; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España.
Ferrer-Márquez M; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España.
Reina Duarte Á; Cirugía General y del Aparato Digestivo, Hospital Universitario Torrecárdenas, España.

Rev Esp Enferm Dig ; 116(1): 46-47, 2024 Jan.

Article de En | MEDLINE | ID: mdl-37073711

ABSTRACT

ABSTRACT

An analysis of the prognostic impact of up to 36 immuno-inflammatory indices at 3 different times during the diagnostic-therapeutic process for gastric cancer. The dependent variable was disease-free survival at 3 years. The independent factors obtained were combined with TNM to provide an improved prognostic model.

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'estomac Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Rev Esp Enferm Dig Sujet du journal: GASTROENTEROLOGIA Année: 2024 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google